GAIN THERAPEUTICS INC (GANX)
US36269B1052 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to GANX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.55. This target is 176.48% above the current price.
GANX was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about GANX.
In the previous month the buy percentage consensus was at a similar level.
GANX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-23 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-27 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-12-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | Maxim Group | Initiate | Buy |
| 2023-08-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-12 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-27 | Chardan Capital | Maintains | Buy |
| 2022-12-09 | Chardan Capital | Initiate | Buy |
| 2022-11-25 | Oppenheimer | Maintains | Outperform |
| 2022-11-14 | BTIG | Maintains | Buy |
| 2022-11-14 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-19 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2021-11-03 | B. Riley Securities | Initiate | Buy |